The Circulating Tumor Cell Market (CTC) refers to the segment of oncological diagnostics and therapeutics devoted to the detection, release and characterization of tumor cells. This rejects primary or metastatic tumors in the blood circulation. CTCs act as a key biomarker for progression, recurrence and cancer metastasis, making the critical direction for precise oncology. The main ob... https://www.metatechinsights.com/industry-insights/circulating-tumor-cells-market-2424